MBBS OSCE · Paediatrics
OSCE — Childhood Leukaemia
Eight-minute OSCE station on Childhood Leukaemia: focused history, examination priorities, investigations, emergency and definitive management.
On this page
Study tools
Exam tags
Brief (to candidate)
You will assess a patient with a presentation consistent with Childhood Leukaemia.
You have 8 minutes to take a focused history, outline examination, investigations, and management including red flags.
Clinical context
Childhood leukaemia is the most common childhood malignancy (30% of all childhood cancers). Acute lymphoblastic leukaemia (ALL) accounts for 75-80%; acute myeloid leukaemia (AML) 15-20%. Peak age: 2-5 years. Presentation: bone marrow failure (anaemia, infection, bleeding), organ infiltration (hepatosplenomegaly, lymphadenopathy, CNS). Diagnosis: FBC + blood film + bone marrow aspirate (morphology, flow cytometry, cytogenetics). Treatment: risk-stratified chemotherapy. 5-year survival ALL: 90%, AML: 65-70%.
Candidate tasks
- Clarify onset, severity, associated features, and red-flag symptoms.
- State focused examination priorities.
- List first-line investigations and any named score/criteria.
- Give immediate resuscitation steps.
- Outline definitive management with doses/routes where standard.
- Name complications and disposition (ward / HDU / theatre / discharge safety-net).
- Mention one special-population modifier (pregnancy, child, elderly, CKD).
Examiner checklist
| Domain | Pass behaviours |
|---|---|
| Definition | Correct working diagnosis language |
| Assessment | Focused, prioritised, red flags sought |
| Investigations | Appropriate first-line + interpretation |
| Emergency care | ABC / time-critical actions first |
| Definitive care | Specific drugs/procedures, not generic phrases |
| Safety | id: 1 |
| Safety | id: 2 |
| Safety | id: 3 |
| Communication | Clear plan and safety-netting |
Model outline
Lead with the working diagnosis and life threats. Resuscitate before definitive tests when unstable. Use guideline-standard therapy with named agents and doses. Document escalation criteria and follow-up. A safe candidate is specific, structured, and never delays critical care for non-urgent imaging.